Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    18442345 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
Condition: Smoking Cessation
Intervention: Drug: varenicline (CP-526,555)
2 Completed A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
Condition: Smoking Cessation
Intervention: Drug: varenicline (CP-526,555)
3 Completed Human Laboratory Study Of Varenicline in Smokers
Condition: Nicotine Dependence
Interventions: Drug: Placebo;   Drug: Varenicline

Indicates status has not been verified in more than two years